The average cost per patient over one year after an exacerbation of COPD treated in the emergency room or admitted is more than 6,000 euros

COPD Study Exacerbations of COPD moderate and severe are associated with a poorer quality of life and a poorer prognosis for patients, in addition to leading to a high health cost. This is one of the conclusions of COHERENT-COPD study (Clinical outcomes, use of healthcare resources and associated costs in patients with COPD), produced by the AstraZeneca Pharmaceuticals.

According to the conclusions of this study, which analyzed patients treated in the emergencies or entered Hospital October 12 of Madrid for one year, mortality per year in patients diagnosed with Exacerbation of COPD severe is high and is strongly influenced by age and the coexistence of heart failure.

As the doctor explained Carlos Alvarez Martinez, Head of the Pneumology Section of the 12 de Octubre University Hospital in Madrid and Associate Professor at the Faculty of Medicine of the Complutense University of Madrid: “The study showed that the coexistence of heart failure it is common in patients with exacerbations of COPD, affecting almost a third of patients, and in people with both situations, mortality on admission or in the following year is significantly higher”.

One-year mortality in patients diagnosed with a severe exacerbation of COPD is high and is strongly influenced by age and the coexistence of heart failure.

Sanitary ribs

Concerning the cost of care, the COHERENT-COPD study estimates that the average cost per patient in the 365 days following an exacerbation of COPD treated in the Emergency Department is greater than 6,000 euros. In addition, more than half of the costs associated with COPD are due to hospitalization costs.

The COHERENT-COPD study estimates that the average cost per patient in the 365 days following an exacerbation of COPD treated in the emergency room is greater than 6,000 euros.

In this sense, Dr. Álvarez pointed out that “emergency care represents 12% of the calculated costs, but the highest costs are those associated with hospitalization, which bears 45% of expenses and 43% of receiptsbecause it must be taken into account that more than a third of patients discharged from hospital will be readmitted in the following months”.

Prevention of COPD exacerbations

For its part, Ana Perez, AstraZeneca Spain’s Director of Medical and Regulatory Affairs said that “the COHERENT-COPD study revealed the need to implement strategies to prevent exacerbations of COPD”.

Exacerbations or exacerbations of COPD are episodes of worsening of symptomss caused by a local and generalized increase in inflammation. They are distinguished by worsening dyspnea or a feeling of choking or shortness of breath, coughing, and the amount and color of sputum.

Exacerbations or exacerbations of COPD are episodes of worsening symptoms caused by a local and generalized increase in inflammation.

Exacerbation of COPD is associated with a significant increase in the rate of impaired lung function, to a significant reduction in quality of life and life expectancy and an increased risk of mortality. In addition, an exacerbation leading to hospitalization increases the risk of death.

Although the frequency of exacerbations varies from patient to patient, the average is between 1 and 4 times a year. “What we do know are the factors associated with greater frequency and severity of these episodes, which include advanced age, severity of COPD, continued smoking, prior admissions, or coexistence with other diseases such as heart disease or diabetes. In addition, when you have an exacerbation, the probability of having a second one increases a lot, and if you have two or more, the probability is much greater”, detailed this expert.

Improving lung function, reducing exacerbations, and controlling everyday symptoms such as dyspnea are treatment goals in the management of COPD.

Improving lung function, reducing exacerbations, and controlling everyday symptoms such as dyspnea are treatment goals in the management of COPD. However, preventing exacerbations is not always possible. In this regard, Dr. Álvarez Martínez pointed out that adherence to inhaled treatment, smoking cessation, following the respiratory rehabilitation and vaccination program, having adequate nutrition, avoiding excessive thinness and obesity, exercising or having an active life, are some of the recommendations that could be effective in reducing the frequency and severity of exacerbations.

“There are also specific programs for the most serious patients and those with higher incomes, such as those fragile COPD programs and strategies for chronic patients, who seek more individualized care,” concluded the doctor.

COHERENT-COPD study

The COHERENT-COPD study analyzes patients seen in the emergency room or admitted to the 12 de Octubre hospital in Madrid for an exacerbation of COPD and their evolution over the following year is studied. Its objective is to identify those who require increased monitoring and individualized treatment and thus be able to improve their quality of life and reduce the episodes of aggravation which increase the risk of mortality.

The analyzed results, which include 2,384 patients, provide valuable information about patients with exacerbations of COPD severe enough to be treated in hospital.

The analyzed results, which include 2,384 patients, provide valuable information about patients with exacerbations of COPD severe enough to be treated in hospital: both their characteristics and associated diseases, the treatments used, the length of hospitalization and the prognosis, in terms of mortality and readmissions.

Leave a Comment